{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:23:29Z","timestamp":1790619809267,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T00:00:00Z","timestamp":1436745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T00:00:00Z","timestamp":1436745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/leu.2015.182","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T06:41:29Z","timestamp":1436769689000},"page":"182-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation"],"prefix":"10.1038","volume":"30","author":[{"given":"F","family":"Pozzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Bittolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Arruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bulian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Macor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Tissino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Gizdic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F M","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bomben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Zucchetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Degan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"D'Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Chiarenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Zaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Pozzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gaidano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Del Poeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Deaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Gattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Dal Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,13]]},"reference":[{"key":"BFleu2015182_CR1","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008; 111: 5446\u20135456.","journal-title":"Blood"},{"key":"BFleu2015182_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/ajh.23491","volume":"88","author":"M Hallek","year":"2013","unstructured":"Hallek M . Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment. Am J Hematol 2013; 88: 803\u2013816.","journal-title":"Am J Hematol"},{"key":"BFleu2015182_CR3","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1084\/jem.20110921","volume":"208","author":"G Fabbri","year":"2011","unstructured":"Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 2011; 208: 1389\u20131401.","journal-title":"J Exp Med"},{"key":"BFleu2015182_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature10113","volume":"475","author":"XS Puente","year":"2011","unstructured":"Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, Villamor N et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101\u2013105.","journal-title":"Nature"},{"key":"BFleu2015182_CR5","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","volume":"121","author":"D Rossi","year":"2013","unstructured":"Rossi D, Rasi S, Spina V, Bruscaggin A, Monti S, Ciardullo C et al. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood 2013; 121: 1403\u20131412.","journal-title":"Blood"},{"key":"BFleu2015182_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng.1032","volume":"44","author":"V Quesada","year":"2012","unstructured":"Quesada V, Conde L, Villamor N, Ordonez GR, Jares P, Bassaganyas L et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 2012; 44: 47\u201352.","journal-title":"Nat Genet"},{"key":"BFleu2015182_CR7","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","volume":"365","author":"L Wang","year":"2011","unstructured":"Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011; 365: 2497\u20132506.","journal-title":"N Engl J Med"},{"key":"BFleu2015182_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/bjh.12128","volume":"160","author":"G Del Poeta","year":"2013","unstructured":"Del Poeta G, Dal Bo M, Del Principe MI, Pozzo F, Rossi FM, Zucchetto A et al. Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia. Br J Haematol 2013; 160: 415\u2013418.","journal-title":"Br J Haematol"},{"key":"BFleu2015182_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3324\/haematol.2011.060129","volume":"97","author":"I Del Giudice","year":"2012","unstructured":"Del Giudice I, Rossi D, Chiaretti S, Marinelli M, Tavolaro S, Gabrielli S et al. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL. Haematologica 2012; 97: 437\u2013441.","journal-title":"Haematologica"},{"key":"BFleu2015182_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","volume":"119","author":"D Rossi","year":"2012","unstructured":"Rossi D, Rasi S, Fabbri G, Spina V, Fangazio M, Forconi F et al. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 2012; 119: 521\u2013529.","journal-title":"Blood"},{"key":"BFleu2015182_CR11","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1084\/jem.20111855","volume":"208","author":"C Lobry","year":"2011","unstructured":"Lobry C, Oh P, Aifantis I . Oncogenic and tumor suppressor functions of Notch in cancer: it\u2019s NOTCH what you think. J Exp Med 2011; 208: 1931\u20131935.","journal-title":"J Exp Med"},{"key":"BFleu2015182_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev.immunol.021908.132719","volume":"28","author":"JS Yuan","year":"2010","unstructured":"Yuan JS, Kousis PC, Suliman S, Visan I, Guidos CJ . Functions of notch signaling in the immune system: consensus and controversies. Annu Rev Immunol 2010; 28: 343\u2013365.","journal-title":"Annu Rev Immunol"},{"key":"BFleu2015182_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1101\/gad.211912.112","volume":"27","author":"D Castel","year":"2013","unstructured":"Castel D, Mourikis P, Bartels SJ, Brinkman AB, Tajbakhsh S, Stunnenberg HG . Dynamic binding of RBPJ is determined by Notch signaling status. Genes Dev 2013; 27: 1059\u20131071.","journal-title":"Genes Dev"},{"key":"BFleu2015182_CR14","doi-asserted-by":"publisher","first-page":"8342","DOI":"10.1038\/sj.onc.1205094","volume":"20","author":"RL Davis","year":"2001","unstructured":"Davis RL, Turner DL . Vertebrate hairy and enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning. Oncogene 2001; 20: 8342\u20138357.","journal-title":"Oncogene"},{"key":"BFleu2015182_CR15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1126\/science.7725102","volume":"268","author":"JJ Hsieh","year":"1995","unstructured":"Hsieh JJ, Hayward SD . Masking of the CBF1\/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2. Science 1995; 268: 560\u2013563.","journal-title":"Science"},{"key":"BFleu2015182_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jcp.10208","volume":"194","author":"T Iso","year":"2003","unstructured":"Iso T, Kedes L, Hamamori Y . HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 2003; 194: 237\u2013255.","journal-title":"J Cell Physiol"},{"key":"BFleu2015182_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/377355a0","volume":"377","author":"S Jarriault","year":"1995","unstructured":"Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A . Signalling downstream of activated mammalian Notch. Nature 1995; 377: 355\u2013358.","journal-title":"Nature"},{"key":"BFleu2015182_CR18","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1242\/dev.124.20.4133","volume":"124","author":"H Kato","year":"1997","unstructured":"Kato H, Taniguchi Y, Kurooka H, Minoguchi S, Sakai T, Nomura-Okazaki S et al. Involvement of RBP-J in biological functions of mouse Notch1 and its derivatives. Development 1997; 124: 4133\u20134141.","journal-title":"Development"},{"key":"BFleu2015182_CR19","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1073\/pnas.0603371103","volume":"103","author":"A Klinakis","year":"2006","unstructured":"Klinakis A, Szabolcs M, Politi K, Kiaris H, Artavanis-Tsakonas S, Efstratiadis A . Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. Proc Natl Acad Sci USA 2006; 103: 9262\u20139267.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015182_CR20","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1101\/gad.1450406","volume":"20","author":"AP Weng","year":"2006","unstructured":"Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia\/lymphoma. Genes Dev 2006; 20: 2096\u20132109.","journal-title":"Genes Dev"},{"key":"BFleu2015182_CR21","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1182\/blood-2008-02-139725","volume":"113","author":"E Rosati","year":"2009","unstructured":"Rosati E, Sabatini R, Rampino G, Tabilio A, Di IM, Fettucciari K et al. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood 2009; 113: 856\u2013865.","journal-title":"Blood"},{"key":"BFleu2015182_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.blre.2010.09.004","volume":"25","author":"M Paganin","year":"2011","unstructured":"Paganin M, Ferrando A . Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia. Blood Rev 2011; 25: 83\u201390.","journal-title":"Blood Rev"},{"key":"BFleu2015182_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269\u2013271.","journal-title":"Science"},{"key":"BFleu2015182_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2141.2010.08368.x","volume":"151","author":"P Sportoletti","year":"2010","unstructured":"Sportoletti P, Baldoni S, Cavalli L, Del PB, Bonifacio E, Ciurnelli R et al. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. Br J Haematol 2010; 151: 404\u2013406.","journal-title":"Br J Haematol"},{"key":"BFleu2015182_CR25","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/leu.2013.319","volume":"28","author":"F Arruga","year":"2014","unstructured":"Arruga F, Gizdic B, Serra S, Vaisitti T, Ciardullo C, Coscia M et al. Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia. Leukemia 2014; 28: 1060\u20131070.","journal-title":"Leukemia"},{"key":"BFleu2015182_CR26","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1182\/blood-2014-01-546150","volume":"123","author":"S Stilgenbauer","year":"2014","unstructured":"Stilgenbauer S, Schnaiter A, Paschka P, Zenz T, Rossi M, Dohner K et al. Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial. Blood 2014; 123: 3247\u20133254.","journal-title":"Blood"},{"key":"BFleu2015182_CR27","first-page":"1640","volume":"8","author":"E Matutes","year":"1994","unstructured":"Matutes E, Owusu-Ankomah K, Morilla R, Garcia MJ, Houlihan A, Que TH et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640\u20131645.","journal-title":"Leukemia"},{"key":"BFleu2015182_CR28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1182\/blood-2007-05-092486","volume":"111","author":"V Gattei","year":"2008","unstructured":"Gattei V, Bulian P, Del Principe MI, Zucchetto A, Maurillo L, Buccisano F et al. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. Blood 2008; 111: 865\u2013873.","journal-title":"Blood"},{"key":"BFleu2015182_CR29","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/leu.2011.369","volume":"26","author":"A Zucchetto","year":"2012","unstructured":"Zucchetto A, Vaisitti T, Benedetti D, Tissino E, Bertagnolo V, Rossi D et al. The CD49d\/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells. Leukemia 2012; 26: 1301\u20131312.","journal-title":"Leukemia"},{"key":"BFleu2015182_CR30","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2013-02-486209","volume":"121","author":"D Rossi","year":"2013","unstructured":"Rossi D, Spina V, Bomben R, Rasi S, Dal-Bo M, Bruscaggin A et al. Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. Blood 2013; 121: 4902\u20134905.","journal-title":"Blood"},{"key":"BFleu2015182_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1182\/blood-2011-10-386144","volume":"119","author":"V Balatti","year":"2012","unstructured":"Balatti V, Bottoni A, Palamarchuk A, Alder H, Rassenti LZ, Kipps TJ et al. NOTCH1 mutations in CLL associated with trisomy 12. Blood 2012; 119: 329\u2013331.","journal-title":"Blood"},{"key":"BFleu2015182_CR32","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/leu.2012.44","volume":"26","author":"R Bomben","year":"2012","unstructured":"Bomben R, Gobessi S, Dal BM, Volinia S, Marconi D, Tissino E et al. The miR-17 approximately 92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes. Leukemia 2012; 26: 1584\u20131593.","journal-title":"Leukemia"},{"key":"BFleu2015182_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/leu.2010.291","volume":"25","author":"I Saborit-Villarroya","year":"2011","unstructured":"Saborit-Villarroya I, Vaisitti T, Rossi D, D'Arena G, Gaidano G, Malavasi F et al. E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia. Leukemia 2011; 25: 479\u2013488.","journal-title":"Leukemia"},{"key":"BFleu2015182_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbrc.2009.09.059","volume":"390","author":"T Sugimoto","year":"2009","unstructured":"Sugimoto T, Tomita A, Hiraga J, Shimada K, Kiyoi H, Kinoshita T et al. Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation. Biochem Biophys Res Commun 2009; 390: 48\u201353.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFleu2015182_CR35","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrm2009","volume":"7","author":"SJ Bray","year":"2006","unstructured":"Bray SJ . Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 2006; 7: 678\u2013689.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFleu2015182_CR36","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H Dohner","year":"2000","unstructured":"Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910\u20131916.","journal-title":"N Engl J Med"},{"key":"BFleu2015182_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-2141.2008.07012.x","volume":"141","author":"CS Tam","year":"2008","unstructured":"Tam CS, Otero-Palacios J, Abruzzo LV, Jorgensen JL, Ferrajoli A, Wierda WG et al. Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients. Br J Haematol 2008; 141: 36\u201340.","journal-title":"Br J Haematol"},{"key":"BFleu2015182_CR38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1073\/pnas.85.1.208","volume":"85","author":"TF Tedder","year":"1988","unstructured":"Tedder TF, Streuli M, Schlossman SF, Saito H . Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes. Proc Natl Acad Sci USA 1988; 85: 208\u2013212.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015182_CR39","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1182\/blood-2008-08-175208","volume":"113","author":"J Hiraga","year":"2009","unstructured":"Hiraga J, Tomita A, Sugimoto T, Shimada K, Ito M, Nakamura S et al. Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance. Blood 2009; 113: 4885\u20134893.","journal-title":"Blood"},{"key":"BFleu2015182_CR40","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1038\/leu.2010.157","volume":"24","author":"R Shimizu","year":"2010","unstructured":"Shimizu R, Kikuchi J, Wada T, Ozawa K, Kano Y, Furukawa Y . HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells. Leukemia 2010; 24: 1760\u20131768.","journal-title":"Leukemia"},{"key":"BFleu2015182_CR41","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00277-014-2117-x","volume":"93","author":"MD Bo","year":"2014","unstructured":"Bo MD, Del Principe MI, Pozzo F, Ragusa D, Bulian P, Rossi D et al. NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. Ann Hematol 2014; 93: 1765\u20131774.","journal-title":"Ann Hematol"},{"key":"BFleu2015182_CR42","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1182\/blood.V98.12.3383","volume":"98","author":"J Golay","year":"2001","unstructured":"Golay J, Lazzari M, Facchinetti V, Bernasconi S, Borleri G, Barbui T et al. CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59. Blood 2001; 98: 3383\u20133389.","journal-title":"Blood"},{"key":"BFleu2015182_CR43","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/leu.2013.289","volume":"28","author":"P Sportoletti","year":"2014","unstructured":"Sportoletti P, Baldoni S, Del PB, Aureli P, Dorillo E, Ruggeri L et al. A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia. Leukemia 2014; 28: 436\u2013439.","journal-title":"Leukemia"},{"key":"BFleu2015182_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nrd4252","volume":"13","author":"ER Andersson","year":"2014","unstructured":"Andersson ER, Lendahl U . Therapeutic modulation of Notch signalling\u2014are we there yet? Nat Rev Drug Discov 2014; 13: 357\u2013378.","journal-title":"Nat Rev Drug Discov"},{"key":"BFleu2015182_CR45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc1779","volume":"6","author":"S Minucci","year":"2006","unstructured":"Minucci S, Pelicci PG . Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 2006; 6: 38\u201351.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2015182_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","volume":"1","author":"S Ropero","year":"2007","unstructured":"Ropero S, Esteller M . The role of histone deacetylases (HDACs) in human cancer. Mol Oncol 2007; 1: 19\u201325.","journal-title":"Mol Oncol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2015182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015182","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:05:03Z","timestamp":1648742703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2015182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,13]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["BFleu2015182"],"URL":"https:\/\/doi.org\/10.1038\/leu.2015.182","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,13]]},"assertion":[{"value":"16 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}